Columbia Small Cap Value Fund II Class A
Columbia Small Cap Value Fund II Class A (COVAX) Revenue
Annual & quarterly revenue history · segment & region breakdown
COVAX · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsColumbia Small Cap Value Fund II Class A trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Asset ManagementCompare COVAX revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Columbia Small Cap Value Fund II Class A receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Columbia Small Cap Value Fund II Class A reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Columbia Small Cap Value Fund II Class A's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
COVAX revenue · 4 questionsCOVAX's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Columbia Small Cap Value Fund II Class A SEC filings · GAAP · Columbia Small Cap Value Fund II Class A SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026